Mediators of diabetic neuropathy: is hyperglycemia the only culprit?

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current Opinion in Endocrinology, Diabetes & Obesity

• Publication date

  2017-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MED.0000000000000320PMID 28098594PMCID PMC5831542
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association Between Metabolic Syndrome Components and Polyneuropathy in an Obese Population.

  2016cited by this paper
• The role of vitamin D, obesity and physical exercise in regulation of glycemia in Type 2 Diabetes Mellitus patients.

  2016cited by this paper
• Inflammation as a Therapeutic Target for Diabetic Neuropathies

  2016cited by this paper
• A 10‐yr follow‐up study for the detection of peripheral neuropathy in young patients with type 1 diabetes

  2016cited by this paper
• The normal-weight type 2 diabetes phenotype revisited.

  2016cited by this paper
• Self-Reported Physical Activity Using the International Physical Activity Questionnaire (IPAQ) in Australian Adults with Type 2 Diabetes, with and Without Peripheral Neuropathy.

  2016cited by this paper
• Metabolic Syndrome Components Are Associated With Symptomatic Polyneuropathy Independent of Glycemic Status

  2016cited by this paper
• The Relationship between Dyslipidemia and Acute Axonal Function in Type 2 Diabetes Mellitus In Vivo

  2016cited by this paper
• Study of Electrophysiological Changes in Sensory Nerves Among Diabetic Smokers.

  2016cited by this paper
• Recent advances in exploring the genetic susceptibility to diabetic neuropathy.

  2016cited by this paper
• Supervised exercise improves cutaneous reinnervation capacity in metabolic syndrome patients

  2015cited by this paper
• Longitudinal patient-oriented outcomes in neuropathy

  2015cited by this paper
• The epidemiology and risk factors of chronic polyneuropathy

  2015influential reference
• Peripheral Neuropathy and Nerve Dysfunction in Individuals at High Risk for Type 2 Diabetes: The PROMISE Cohort

  2015cited by this paper
• Cardiovascular Risk Factors Increase the Risks of Diabetic Peripheral Neuropathy in Patients With Type 2 Diabetes Mellitus

  2015cited by this paper
• Detection of undisclosed neuropathy and assessment of its impact on quality of life: a survey in 25,000 Romanian patients with diabetes.

  2015cited by this paper
• Peripheral neuropathy is associated with insulin resistance independent of metabolic syndrome

  2015cited by this paper
• Epidemiology of polyneuropathy in diabetes and prediabetes.

  2014cited by this paper
• Diabetic Neuropathies

  2014cited by this paper
• The Role of Insulin Resistance in Diabetic Neuropathy in Koreans with Type 2 Diabetes Mellitus: A 6-Year Follow-Up Study

  2014cited by this paper
• The ε4 Allele of the APOE Gene Is Associated With More Severe Peripheral Neuropathy in Type 2 Diabetic Patients

  2013cited by this paper
• Obesity and hyperlipidemia are risk factors for early diabetic neuropathy.

  2013cited by this paper
• The metabolic syndrome and neuropathy: Therapeutic challenges and opportunities

  2013cited by this paper
• Impaired Glycemia and Diabetic Polyneuropathy

  2012cited by this paper
• ENHANCED GLUCOSE CONTROL FOR PREVENTING AND TREATING DIABETIC NEUROPATHY

  2012cited by this paper
• Triglycerides and Amputation Risk in PatientsWith Diabetes Ten-year follow-up in the DISTANCE study

  2011cited by this paper
• Alcohol consumption and other psycho‐social conditions as important factors in the development of diabetic foot ulcers

  2011cited by this paper
• Triglycerides and Amputation Risk in Patients With Diabetes

  2011cited by this paper
• Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.

  2010cited by this paper
• Elevated Triglycerides Correlate With Progression of Diabetic Neuropathy

  2009cited by this paper
• Hyperlipidemia: a new therapeutic target for diabetic neuropathy

  2009cited by this paper
• Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies

  2009cited by this paper
• Glucose control and vascular complications in veterans with type 2 diabetes.

  2009cited by this paper
• Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics.

  2009cited by this paper
• Diabetic neuropathy: mechanisms to management.

  2008cited by this paper
• Prevalence of Polyneuropathy in Pre-Diabetes and Diabetes Is Associated With Abdominal Obesity and Macroangiopathy

  2008cited by this paper
• Idiopathic neuropathy patients are at high risk for metabolic syndrome.

  2008cited by this paper
• Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle Diabetes Study

  2008cited by this paper
• Prevalence of lower extremity diseases associated with normal glucose levels, impaired fasting glucose, and diabetes among U.S. adults aged 40 or older.

  2007cited by this paper
• Intraepidermal nerve fiber density as a marker of early diabetic neuropathy

  2007cited by this paper
• Faculty Opinions recommendation of Lifestyle intervention for pre-diabetic neuropathy.

  2006cited by this paper
• The Metabolic Syndrome Is a Risk Indicator of Microvascular and Macrovascular Complications in Diabetes

  2006cited by this paper
• Impact of Overweight on Chronic Microvascular Complications in Type 1 Diabetic Patients

  2005cited by this paper
• Vascular risk factors and diabetic neuropathy.

  2005cited by this paper
• Impact of overweight on chronic microvascular complications in type 1 diabetic patients.

  2005cited by this paper
• Vascular risk factors and diabetic neuropathy.

  2005cited by this paper
• Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes

  2004cited by this paper
• The spectrum of neuropathy in diabetes and impaired glucose tolerance

  2003cited by this paper
• The metabolic syndrome influences the risk of chronic complications in patients with Type II diabetes

  2001cited by this paper
• The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM).

  1999cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Hypertension as a Risk Factor for Diabetic Neuropathy: A Prospective Study

  1997cited by this paper
• Incidence of Distal Symmetric (Sensory) Neuropathy in NIDDM: The San Luis Valley Diabetes Study

  1997cited by this paper
• Risk Factors for Diabetic Peripheral Sensory Neuropathy: Results of the Seattle Prospective Diabetic Foot Study

  1997cited by this paper
• Urinary Albumin Excretion as a Predictor of Diabetic Retinopathy, Neuropathy, and Cardiovascular Disease in NIDDM

  1996cited by this paper
• Intensive therapy in adult insulin-dependent diabetes mellitus is associated with improved insulin sensitivity and reserve: a randomized, controlled, prospective study over 5 years in newly diagnosed patients.

  1996cited by this paper
• Effect of intensive diabetes treatment on nerve conduction in the diabetes control and complications trial

  1995cited by this paper
• Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• Impact of Obesity on Neuropathic Late Complications in NIDDM

  1994cited by this paper
• The effect of 8 years of strict glycaemic control on peripheral nerve function in IDDM patients: the Oslo study

  1994cited by this paper
• Risk Factors For Distal Symmetric Neuropathy in NIDDM: The San Luis Valley Diabetes Study

  1994cited by this paper
• The Prevalence of Diabetic Distal Sensory Neuropathy in an English Community

  1992cited by this paper
• Cigarette Smoking and Neuropathy in Diabetic Patients

  1990cited by this paper
• Sensory neuropathy in non-insulin-dependent diabetes mellitus. The San Luis Valley Diabetes Study.

  1990cited by this paper
• Autonomic and Somatosensory Nerve Function After 2 Years of Continuous Subcutaneous Insulin Infusion in Type I Diabetes

  1988cited by this paper
• Influence of Height on Quantitative Sensory, Nerve-Conduction, and Clinical Indices of Diabetic Peripheral Neuropathy

  1987cited by this paper
• Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients. A two-year randomised prospective study.

  1983cited by this paper
• Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients. A two-year randomised prospective study.

  1983cited by this paper

• Innovative strategies for diabetic peripheral neuropathy: From clinical management to emerging bioengineering solutions.

  2026cites this paper
• MiR-210-3p is upregulated in diabetic peripheral neuropathy and may be involved in the progression of the disease by targeting brain-derived neurotrophic factor.

  2026cites this paper
• Innovative Diabetes Therapies and Impact on Peripheral and Autonomic Diabetic Neuropathies: A State-of-the-Art Review.

  2026cites this paper
• Mechanism-driven multitarget therapeutics for diabetic peripheral neuropathy.

  2025cites this paper
• Nutrient metabolism and complications of type 2 diabetes mellitus: implications for rehabilitation and precision care

  2025cites this paper
• A Review of Prediabetes: Diagnosis, Consequences and Interventions

  2025cites this paper
• Association of long noncoding RNA MEG3 genetic variants with the risk of diabetic neuropathy

  2025cites this paper
• Development and assessment of an early diagnostic approach for painful diabetic peripheral neuropathy using basic clinical and laboratory parameters.

  2025cites this paper
• Effect of Yoga and Naturopathy Intervention on Neuropathic Pain in a Patient Suffering from Diabetic Peripheral Neuropathy: A Clinical Case Report

  2025cites this paper
• Comparison of inflammatory markers and nerve conduction studies in prediabetes and type two diabetes mellitus: A possible role in neuropathy

  2025cites this paper
• Preparation of quercetin long-circulating liposomes and their therapeutic effect on diabetic peripheral neuropathy

  2025cites this paper
• Effects of Anti-Diabetic Drugs on Erectile Dysfunction: A Systematic Review and Meta-Analysis

  2025cites this paper
• Association of PTX3 Genetic Variants With Development of Diabetic Neuropathy

  2025cites this paper
• High HOMA2‐B: A novel risk factor for diabetic peripheral neuropathy beyond metabolic syndrome components in type 2 diabetes

  2025cites this paper
• Exploring the Effects of Palm Tocotrienol-Rich Fraction in Diabetic Peripheral Neuropathy Rat’s Model: An Untargeted Metabolomic Profiling and Correlation Study

  2025cites this paper
• Research progress of the effective active ingredients of Astragalus mongholicus in the treatment of diabetic peripheral neuropathy.

  2024cites this paper
• Synergistic Impact of Mangiferin with Metformin and Gliclazide on Diabetic Neuropathic Pain

  2024cites this paper
• Construction and validation of a nomogram model for predicting diabetic peripheral neuropathy

  2024cites this paper
• Painful Diabetic Neuropathy: Sex-Specific Mechanisms and Differences from Animal Models to Clinical Outcomes

  2024cites this paper
• The global and regional burden of diabetic peripheral neuropathy

  2024cites this paper
• Obesity as a risk factor for neuropathy: a case-control study

  2024cites this paper
• Visceral Adiposity as an Independent Risk Factor for Diabetic Peripheral Neuropathy in Type 2 Diabetes Mellitus: A Retrospective Study

  2024cites this paper
• miR-34a-5p Predicts the Risk of Diabetic Neuropathic Pain and Mediates Neuroinflammation in Microglia via Targeting ENPP3

  2024cites this paper
• C-peptide: an essential ally in microvascular complications of type 2 diabetes mellitus and obesity

  2024cites this paper
• Association between gut microbiota and diabetic microvascular complications: a two-sample Mendelian randomization study

  2024cites this paper
• Recent Advances in Biomolecular Patho-Mechanistic Pathways behind the Development and Progression of Diabetic Neuropathy

  2024cites this paper
• Humanin’s impact on pain markers and neuronal viability in diabetic neuropathy model

  2024cites this paper
• AMPK and Beyond: The Signaling Network Controlling RabGAPs and Contraction-Mediated Glucose Uptake in Skeletal Muscle

  2024cites this paper
• Estimation of Apelin Levels in Iraqi Patients with Type II Diabetic Peripheral Neuropathy

  2023cites this paper
• The Experience of Peripheral Neuropathy Symptoms in Breast Cancer Survivors With Diabetes

  2023cites this paper
• TNF-α levels, hypertension, glycated hemoglobin, and lower limb pain are predictors of diabetic neuropathy

  2023cites this paper
• Obesity-Associated Neuropathy: Recent Preclinical Studies and Proposed Mechanisms

  2022influential citation
• Liraglutide Attenuates Glucolipotoxicity-Induced RSC96 Schwann Cells’ Inflammation and Dysfunction

  2022cites this paper
• Schwann cells-derived exosomal miR-21 participates in high glucose regulation of neurite outgrowth

  2022cites this paper
• ECW/TBW is increased in type 1 diabetes mellitus patients with diabetic peripheral neuropathy: a retrospective case-control study

  2022cites this paper
• Sodium Glucose Cotransporter-2 Inhibitor Protects Against Diabetic Neuropathy and Nephropathy in Modestly Controlled Type 2 Diabetes: Follow-Up Study

  2022cites this paper
• Systems Biology to Address Unmet Medical Needs in Neurological Disorders.

  2022cites this paper
• Influence of intermittent fasting on prediabetes-induced neuropathy: Insights on a novel mechanistic pathway

  2022cites this paper
• Median Nerve Affection in Hypertensive Patients with and without Diabetes High-Resolution Ultrasound Assessment

  2022influential citation
• Differences and Similarities in Neuropathy in Type 1 and 2 Diabetes: A Systematic Review

  2021cites this paper
• Peripheral sensory nerve hyperaesthesia in women with polycystic ovary syndrome.

  2021cites this paper
• The Impact of Glycemic Control on Retinal Photoreceptor Layers and Retinal Pigment Epithelium in Patients With Type 2 Diabetes Without Diabetic Retinopathy: A Follow-Up Study

  2021cites this paper
• Comparison of pain and quality of life between individuals with and without diabetic neuropathy

  2021cites this paper
• Serum Free Triiodothyronine Is Inversely Associated With Diabetic Peripheral Neuropathy but Not With Carotid Atherosclerotic Lesions in Type 2 Diabetic Patients With Euthyroid Function

  2021cites this paper
• Prevalence and Clinical Significance of Subclinical Hypothyroidism in Diabetic Peripheral Neuropathy

  2021cites this paper
• Human IAPP is a contributor to painful diabetic peripheral neuropathy

  2021cites this paper
• A Comparison of Neuropathy Quality of Life Tools: Norfolk QOL-DN, PN-QOL-97, and NeuroQOL-28

  2021cites this paper
• Schwann cell p75 neurotrophin receptor modulates small fiber degeneration in diabetic neuropathy

  2020cites this paper
• Protection from neuropathy in extreme duration type 1 diabetes

  2020cites this paper
• Burning sensation in the feet and glycosylated haemoglobin levels in Swedish- and non-Swedish-born primary healthcare patients.

  2020cites this paper
• Sleep Quality and Diabetic Peripheral Neuropathy among Patients with Type 2 Diabetes: A Cross-sectional Survey in Jordan.

  2020cites this paper
• Spectrum of diabetic neuropathies

  2020cites this paper
• Biomarkers in diabetic neuropathy

  2020cites this paper
• Amyloid Proteins and Peripheral Neuropathy

  2020cites this paper
• Postoperative management and rehabilitation after the supercharged end-to-side anterior interosseous nerve to ulnar motor nerve transfer: A report of 3 cases.

  2020cites this paper
• The bone marrow-derived mesenchymal stem cells (BMSCs) alleviate diabetic peripheral neuropathy induced by STZ via activating GSK-3β/β-catenin signaling pathway.

  2020cites this paper
• A diabeteses neuropathia és egyéb szövődmények előfordulása a Debreceni Egyetem Diabeteses Neuropathia Centrumában Diabetic neuropathy and other diabetic complications at the Diabetic Neuropathy Center of the University of Debrecen

  2020cites this paper
• Superimposition of hypertension on diabetic peripheral neuropathy affects small unmyelinated sensory nerves in the skin and myelinated tibial and sural nerves in rats with alloxan-induced type 1 diabetes

  2020cites this paper
• Metabolic Factors, Lifestyle Habits, and Possible Polyneuropathy in Early Type 2 Diabetes: A Nationwide Study of 5,249 Patients in the Danish Centre for Strategic Research in Type 2 Diabetes (DD2) Cohort

  2020cites this paper
• The emerging role of dyslipidemia in diabetic microvascular complications.

  2020cites this paper
• Dunaliella salina Attenuates Diabetic Neuropathy Induced by STZ in Rats: Involvement of Thioredoxin

  2020cites this paper
• Prevalence of People at Risk of Developing Diabetes Mellitus and the Involvement of Community Pharmacies in a National Screening Campaign: A Pioneer Action in Brazil

  2020cites this paper
• The impact of demographic and clinical characteristics on diabetic painful neuropathy

  2020cites this paper
• Smoking and Diabetes Control in Adults With Type 1 and Type 2 Diabetes: A Nationwide Study From the 2018 National Program for Prevention and Control of Diabetes of Iran.

  2020cites this paper
• Diabetic neuropathy and neuropathic pain: a (con)fusion of pathogenic mechanisms?

  2020cites this paper
• Statin Therapy and Risk of Polyneuropathy in Type 2 Diabetes: A Danish Cohort Study

  2020cites this paper
• Prevalence of people at risk of developing type 2 diabetes mellitus and the involvement of community pharmacies in a national screening campaign: a pioneer action in Brazil

  2020cites this paper
• Long-Term Metformin Treatment and Risk of Peripheral Neuropathy in Older Veterans.

  2020cites this paper
• Diagnosis of Neuropathy and Risk Factors for Corneal Nerve Loss in Type 1 and Type 2 Diabetes: A Corneal Confocal Microscopy Study

  2020cites this paper
• Early disruption of nerve mitochondrial and myelin lipid homeostasis in obesity-induced diabetes

  2020cites this paper
• Diabetische Neuropathie – Relevanz metabolischer Phänotypen

  2020cites this paper
• Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention.

  2019cites this paper
• Prevalence of risk factors promoting Diabetic neuropathy .

  2019cites this paper
• Effect of Early and Late Interventions with Dietary Oils on Vascular and Neural Complications in a Type 2 Diabetic Rat Model

  2019cites this paper
• ER stress response mediates diabetic microvascular complications.

  2019cites this paper
• A COMPARATIVE STUDY OF DYSLIPIDAEMIA IN DIABETIC PATIENTS WITH AND WITHOUT NEUROPATHY

  2019cites this paper
• Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus.

  2019cites this paper
• TOTAL BODY ADIPOSITY, TRIGLYCERIDES, AND LEG FAT ARE INDEPENDENT RISK FACTORS FOR DIABETIC PERIPHERAL NEUROPATHY IN CHINESE PATIENTS WITH TYPE 2 DIABETES MELLITUS.

  2019cites this paper
• Peripheral nervous system involvement in systemic lupus erythematosus: a retrospective study on prevalence, associated factors and outcome

  2019cites this paper
• Associations between metformin use and vitamin B12 levels, anemia, and neuropathy in patients with diabetes: a meta‐analysis

  2019cites this paper
• The Effects of Diabetes and High-Fat Diet on Polymodal Nociceptor and Cold Thermoreceptor Nerve Terminal Endings in the Corneal Epithelium.

  2019cites this paper
• Diabetic Peripheral Neuropathies (DPNs) from Basic and Clinical Aspects

  2019cites this paper
• Glycolaldehyde induces sensory neuron death through activation of the c-Jun N-terminal kinase and p-38 MAP kinase pathways

  2019cites this paper
• Correlation between serum uric acid and diabetic peripheral neuropathy in T2DM patients.

  2018cites this paper
• Vascular Endothelial Growth Factor 936 C/T Gene Polymorphism in Indonesian Subjects with Diabetic Polyneuropathy

  2018cites this paper
• The Association Between the Levels of Thyroid Hormones and Peripheral Nerve Conduction in Patients with Type 2 Diabetes Mellitus.

  2018cites this paper
• Variations in adrenal gland medulla and dopamine effects induced by the lack of Irs2

  2018cites this paper
• Observational clinical and nerve conduction study on effects of a nutraceutical combination on painful diabetic distal symmetric sensory-motor neuropathy in patients with diabetes type 1 and type 2.

  2018cites this paper
• The relationship between diabetic risk factors, diabetic complications and salt intake.

  2018cites this paper
• Impact of Normoglycemia in Reducing Microvascular Complications in Patients with Type 2 Diabetes: A Follow-Up Study

  2018cites this paper
• Risk Factors for Incident Diabetic Polyneuropathy in a Cohort With Screen-Detected Type 2 Diabetes Followed for 13 Years: ADDITION-Denmark

  2018cites this paper
• Electrodiagnosis in the Patient with Metabolic Syndrome: Adding Value to Patient Care.

  2018cites this paper
• Protection of insulin‑like growth factor 1 on experimental peripheral neuropathy in diabetic mice.

  2018cites this paper
• Nociceptin/orphanin FQ opioid peptide‐receptor expression in pachyonychia congenita

  2018cites this paper
• The Potential Role of Fatty Acids in Treating Diabetic Neuropathy

  2018cites this paper
• Improvement in Neuropathy Outcomes With Normalizing HbA1c in Patients With Type 2 Diabetes

  2018cites this paper
• Expression and clinical significance of microRNA 146 a in peripheral blood mononuclear cells from type 2 diabetic neuropathy patients

  2018cites this paper
• Risk-Factor Trajectories Preceding Diabetic Polyneuropathy: ADDITION-Denmark

  2018cites this paper
• Diabetic Peripheral Neuropathy and Associated Pain: Emerging and Updated Research.

  2017cites this paper
• Glycaemic Control and Complications of Type II Diabetes Mellitus - At Two Public Sector Diabetic Clinics

  2017cites this paper